FindMyKOL
Clinical trialNCT04457193Enrolling, by, invitationObservational

Outcomes After Transoral Incisionless Fundoplication (TIF) Following Successful Endoscopic Ablation for Barrett's Esophagus

NCT04457193 is an observational study sponsored by Johns Hopkins University. As of 21 Nov 2026, it is enrolling by invitation only. It studies Barrett Esophagus and Transoral Incisionless Fundoplication. The registry lists an enrollment of 50 participants at 1 site in 1 country. The registry lists a start date of 7 Jun 2018 and a primary completion date of 7 Jun 2027.

SponsorJohns Hopkins University →Enrollment50Barrett EsophagusTransoral Incisionless Fundoplication
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04457193
FieldValue
Registry IDNCT04457193
StatusEnrolling by invitation
Study typeObservational study
Lead sponsorJohns Hopkins University
Enrollment50
Registered sites1
Countries1
ConditionsBarrett Esophagus and Transoral Incisionless Fundoplication
Start7 Jun 2018
Primary completion7 Jun 2027
Study completion7 Jun 2027
Last update posted15 Jun 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Barrett's esophagus (BE) is a precancerous lesion characterized by the replacement of the normal stratified squamous epithelium of the distal esophagus by intestinal metaplasia (IM). Non-dysplastic BE may progress to low-grade dysplasia (LGD), to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Endoscopic ablation is safe and effective for complete eradication of BE. However, recurrence is common. Cumulative incidence rate of BE recurrence is up to 30% in the third year. Thus, achieving complete eradication of IM, patients should undergo surveillance indefinitely with serial endoscopy to assess for recurrence of BE. In addition, BE patients have been committed to life-long proton pump inhibitor (PPI) therapy, but increasing concerns about adverse effects has led to alternative therapies. Studies have showed that laparoscopic Nissen fundoplication may decrease recurrence of BE after endoscopic ablation. Transoral Incisionless Fundoplication (TIF) is an endoscopic procedure that mechanically creates fundoplication similar to traditional operative Nissen fundoplication. The role of TIF in patients with BE whom underwent successful endoscopic ablation has not been fully investigated.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Maryland, United States1 site
  • Saowanee Ngamruengphong

    Baltimore

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04457193

Each answer restates registry values shown on this page.

What is NCT04457193?

NCT04457193 is an observational study sponsored by Johns Hopkins University. It studies Barrett Esophagus and Transoral Incisionless Fundoplication.

Is NCT04457193 recruiting?

As of 21 Nov 2026, it is enrolling by invitation only.

Who leads NCT04457193?

The registry names Saowanee Ngamruengphong (principal investigator, Johns Hopkins University) as the overall official.

Where does NCT04457193 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04457193 expected to complete?

The registry lists a primary completion date of 7 Jun 2027 and a study completion date of 7 Jun 2027. The sponsor last updated the record on 15 Jun 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.